Not just an ophthalmology-focused CRO, Iris Pharma helps clients around the world navigate every stage of the drug and device development process and delivers customized solutions for:

– Assessing possible therapeutic effect in ocular diseases

– Adding value to promising drug candidates or medical devices

– Designing development plans and preclinical packages and carrying out studies to proceed.

They accompany start-up companies, biotechnology companies, large pharmaceutical companies, pharmaceutical labs, universities, research organizations and consultants in their ophthalmology projects.

Iris Pharma’s a la carte services include:

***PRECLINICAL DEVELOPMENT SERVICES*** – Animal efficacy models & in vivo pharmacology studies – GLP regulatory studies (ocular PK, safety and tolerability) – Proof of concept & pilot studies

***INNOVATIVE TECHNOLOGY PLATFORM & TECHNIQUES*** – Bioanalytical testing services – Cellular and molecular biology assays – Non-GMP, non-GLP, early preclinical ocular formulation – Ocular histology

Their assets: – All ophthalmic indications mastered – 70 FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations – State-of-the-art medical and scientific equipment – Highly specialized and qualified staff – CIR agreement